Moonwalk Biosciences

formerly Moonwalk Bio

Moonwalk Biosciences

South San Francisco, United States · Founded 2023 · $155.5M raised

Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$155.5M
Last Round
$70.0M Series BSep 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Moonwalk Biosciences is an epigenetic biology and AI company pioneering therapeutics in adipose biology, driven by deep genetic and epigenetic insights. The company couples an epigenetic discovery platform with precise engineering to open the epigenome as a new class of therapeutic targets, using it to identify novel targets involved in obesity and cardiometabolic disease. Co-founded by CRISPR pioneer Feng Zhang alongside Alex Aravanis, Arash Jamshidi, and Justin Valley, Moonwalk is advancing an early-stage pipeline of precision epigenetic medicines from its South San Francisco, California headquarters.

Summary

Moonwalk Biosciences is a Biotech company based in South San Francisco, United States, founded in 2023. It has raised $155.5M in total across 3 rounds, most recently a $70.0M Series B round in Sep 2026. Investors include Alpha Wave Ventures, YK Bioventures and Khosla Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2026
$70.0M

Sign up to see all 3 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
LifeMine

Therapeutics company working in drug discovery and development using fungi with genomics approach...

Watertown, United States51–200Biotech, Drug Discovery
Venture RoundTotal funding$816.0MAug 2026
Tessera Therapeutics

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

Somerville, United States201–500Biotech, Genomics
Corporate RoundTotal funding$730.0MDec 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Moonwalk Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/moonwalk-biosciences"><img src="https://indexed.vc/api/badge/company/moonwalk-biosciences" alt="Moonwalk Biosciences on Indexed.vc" width="260" height="76" /></a>